Here we built upon our previous study [11], which highlighted alterations in NKp30-B7H6 axis in patients with HCC, and focused on the major NKG2D-MICA/B receptor-ligand axis, that is known to play a principal role in anti-tumor surveillance. This evidence concerns the gene KLRK1 and hepatocellular carcinoma.